The Europe cannabidiol (CBD) market size was estimated at USD 347.7 million in 2023 and is projected to reach USD 1.76 billion by 2030, growing at an impressive compound annual growth rate (CAGR) of 25.8% from 2024 to 2030. The market’s robust expansion is primarily attributed to the increasing legalization and social acceptance of CBD-based products across Europe. As consumer awareness regarding the therapeutic and wellness benefits of cannabidiol grows, companies are introducing a broad range of CBD-infused offerings such as edibles, topicals, oils, and beverages to meet the diverse preferences of consumers. The rapid rise of e-commerce platforms has further accelerated this growth by allowing manufacturers and retailers to reach a wider audience, streamline distribution channels, and increase product visibility. This digital transformation in sales has significantly contributed to the positive growth trajectory of the European CBD industry.

The European CBD market is further characterized by a supportive regulatory framework that has encouraged market development. The legalization of marijuana cultivation and processing in many European countries has opened avenues for startups and small-scale businesses to enter the market and innovate with cannabis-derived products. Companies such as Harmony, Hanfgarten, Cannamedical Pharma GmbH, and Hempfy are among the key players contributing to the proliferation of marijuana-based CBD products in the region. In addition, the growing understanding of CBD’s health benefits, coupled with its easy accessibility and affordability, has driven the increased adoption of CBD oil among consumers. The product’s reputation for aiding relaxation, pain management, and general wellness continues to strengthen its demand in both medical and recreational markets across Europe.

The market offers CBD in several product forms, including capsules, edibles, hemp oil, tinctures, and vaping e-liquids, catering to a wide range of consumer preferences. For example, Eos Scientific under Ambiance Cosmetics launched six lines of cosmetics infused with CBD, including oils, balms, and moisturizers, targeting skincare and wellness consumers. The growing scientific interest in the therapeutic potential of cannabidiol has also encouraged higher investments in research and development activities aimed at exploring new medical applications and improving product efficacy. As more companies enter the market and develop similar product offerings, competition within the CBD sector continues to intensify. This has led to increased innovation, quality enhancement, and diversification in product portfolios, all of which are expanding the market landscape and driving consumer adoption.

Key Market Trends & Insights:

  • The European CBD market is anticipated to experience strong and sustained growth, registering a CAGR of 25.8% over the forecast period, largely supported by the establishment of new hemp production and extraction facilities. Among European countries, the Netherlands dominated the market with the largest share of 23.9% in 2023, driven by its longstanding cultural and regulatory acceptance of cannabis use and well-developed hemp industry.
  • Based on source type, the hemp segment accounted for the highest market share of 56.1% in 2023 and is projected to grow at the fastest rate over the coming years. This growth is primarily fueled by the rising demand from the pharmaceutical sector and increased consumer awareness regarding the natural health benefits of hemp-derived CBD.
  • By end-use, the B2B pharmaceutical segment held the largest revenue share of 74.9% in 2023, reflecting the widespread use of cannabidiol in pharmaceutical formulations, nutraceuticals, and wellness products. This segment is expected to maintain strong growth momentum through 2030 as CBD continues to gain recognition for its therapeutic efficacy and potential in treating various health conditions.
  • Based on sales type, the B2B segment dominated the market with a revenue share of 56.2% in 2023 and is projected to record the fastest CAGR during the forecast period. The increasing number of wholesalers supplying CBD oil and related raw materials to manufacturers across Europe is a key factor driving this trend. The growing integration of CBD oil in product manufacturing and formulation processes is further expanding the reach of the B2B segment.

Order a free sample PDF of the Europe Cannabidiol (CBD) Market Intelligence Study, published by Grand View Research.

Key Companies & Market Share Insights:

Prominent players in the European CBD market are actively pursuing strategies such as strategic partnerships, distribution agreements, and continuous product innovation to strengthen their market presence and enhance competitiveness. For instance, in October 2022, Charlotte’s Web Holdings, Inc. entered into a distribution partnership with Gopuff Retail Company, aimed at improving product accessibility and expanding retail channels. Such collaborations enable companies to diversify product portfolios, optimize distribution networks, and increase market penetration.

Leading players in the CBD industry are focused on delivering technologically advanced and high-quality products to cater to evolving consumer needs. Innovation remains a key competitive factor, as companies introduce new formulations, improve product efficacy, and adopt sustainable production methods. By embracing these strategies, manufacturers are not only expanding their customer base but also contributing to the long-term growth and professionalization of the European CBD market.

Key Players

  • Jazz Pharmaceuticals
  • Canopy Growth Corporation
  • Tilray
  • Aurora Cannabis
  • Maricann, Inc.
  • Organigram Holding, Inc.
  • Isodiol International, Inc.
  • Medical Marijuana, Inc.
  • Elixinol
  • NuLeaf Naturals, LLC
  • Cannoid, LLC
  • CV Sceiences, Inc.
  • CHARLOTTE’S WEB.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

In conclusion, the Europe cannabidiol market is poised for remarkable growth, driven by increasing legalization, consumer awareness, and the expanding acceptance of CBD-based wellness and therapeutic products. The diversification of product forms and the rise of e-commerce platforms have further strengthened market accessibility and consumer reach. Countries such as the Netherlands continue to lead the region due to their progressive stance on cannabis and established production infrastructure. Moreover, strong investment in R&D and strategic collaborations among key players are expected to enhance innovation and product quality. Overall, the market outlook remains highly positive, reflecting Europe’s shift toward natural, health-oriented, and sustainable product solutions.